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set of variables (BP, HR, ECG, VO2, VCO2, VE/VCO2 and VE/VCO2 slope) was
obtained separately at rest, during exercise and in recovery phase in the test. All data
were computed with SPSS windows 17.0. Differences between two groups were
compared using two independent samples t-test, three groups or more than three
groups compared using ANOVA.
(*The indications for termination of testing include leg fatigue, chest pain, chest
distress, breathless, dizziness, severe cardiac arrhythmias and per patient’s request)
Results: 38 CAD patients (male gender, 73.68%; mean age, 60.2910.63 years,
PCI, 68.42%) were included, and there was no adverse cardiac event occurred
during the study. VO2/kg peak, VE/VCO2 nadir and VE/VCO2 slope were slightly
higher in male patients (male: 19.715.17 ml/kg/min, 26.934.422, 25.834.78;
female: 18.652.84 ml/kg/min, 24.43.31, 23.472.74, respectively). Although
statistically not signiﬁcant, the results showed variables in male patients had
slightly higher values. Furthermore, the ratio of male to female patients in our
small study group was 2.8 to 1. This might imply that males are more prone to
suffer CAD or the CAD male patients are more seeking medical treatment. The
difference between age groups was statistically insigniﬁcant. Elder patients (50y
and older, total 30) had slightly lower VO2/kg peak and higher VE/VCO2 nadir and
VE/VCO2 slope than younger adults (younger than 50y, 8 patients) (19.284.44
ml/kg/min, 26.44.12, 25.594.65 vs 20.015.71 ml/kg/min, 25.755.06,
23.573.35, respectively). No signiﬁcant difference was found among different
post-PCI duration groups.
Although statistically no signiﬁcant differences were found based on gender, age
and post-PCI duration, trends were seen that in CAD Chinese male patients the VE/
VCO2 nadir and VE/VCO2 slope were higher than female patients’ and the VE/VCO2
nadir and VE/VCO2 slope were increased as patients aged.
Conclusions: Older CAD Chinese male patients may have a poorer prognosis and
higher mortality than the younger female patients. The CPET offers a comprehensive
assessment tool for the rehabilitation program and should be widely performed in
clinical settings. Most CAD patients post PCI can initiate an exercise rehabilitation
program safely under the direction of doctors.Medical Rehabilitation of Cardiovascular Disease
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Effects of hypoxia training in rabbits with myocardial infarction
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Objectives: To investigate the impact of hypoxia training in rabbits with myocardial
infarction(MI).
Methods: 18 adult male rabbits were randomly divided into three groups: group
SO(sham operated), group MI(myocardial infarction only) and group MI-HT(myo-
cardial infarction plus hypoxia training). MI was induced by left ventricular branch
ligation. Hypoxia training was performed in a hypobaric chamber at the altitude of
4000m, 1 h/day for 4 weeks. At the endpoints, echocardiography, capillary density
and VEGF level were measured.
Results: 4 weeks later, the plasma VEGF levels increased in Groups MI and MI-HT
signiﬁcantly, when compared to group SO. Group MI-HT decreased infarct size
(P<0.05) and increased capillary density (P<0.05) among all groups. Echocardiog-
raphy revealed an increased LV end-diastolic (LVEED) and end-systolic dimensions
(LVESD) but reduced LV ejection fraction (LVEF) in groups MI and MI-HT than in
group SO (P<0.01). Compared with group MI, group MI-HT improved LVEF and
decreased LVEDD and LVESD.
Conclusions: Hypoxia training may improve LV function and reduces LV remodel-
ing, and preserve the cardiac protection after MI insults.Traditional Rehabilitation of Cardiovascular Disease
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Objectives: Adriamycin (ADM) is one of the most effective chemotherapeutic drugs
widely used for the treatment of various malignancies. Unfortunately, evidence sug-
gests that time and dose-dependent ADM therapy induces oxidative stress related
cardiotoxicity and heart failure which restricted clinical use of ADM. DanhongC208 JACC Vol 64/16/Suppl Cinjection (DHI), a traditional Chinese medicine with Danshen (Radix salviae mil-
tiorrhizae) and Honghua (Flos carthami), has been demonstrated to have the abilities
of reducing oxygen free radicals, protecting vascular endothelium, and anti-inﬂam-
matory effect. Thus, we performed a study to determine whether DHI could decrease
the ADM-induced injury in rats and endothelial cells, and investigated the potential
mechanisms.
Methods: Sprague-Dawley rats (28020 g) were randomly assigned to control, ADM
and ADM/DHI group (n¼6). Rats were administered through a single dose of 15
mg.kg1 (i.p.) in ADM and ADM/DHI groups. In ADM/DHI group, DHI at
0.067mL.kg1.d1 (i.p.) was given daily for 2 weeks, starting from 2 h after giving
ADM. Saline was used as control. Transthoracic echocardiography by Vevo 2100
ultrasound system was performed to evaluate left ventricular (LV) systolic and dia-
stolic function at baseline and 3, 7, 14 days after ADM administration. Besides, at the
end of 2 week, the animals were sacriﬁced to evaluate the vascular reactivity by
thoracic ring assay. Human umbilical vein endothelial cell line (Eahy926 cells) were
cultured in vitro. Methyl thiazolyltetrazolium (MTT) and lactate dehydrogenase
(LDH) were performed to determine cell viability. Xanthineoxidase method was
adopted to detect the activity of superoxide dismutases (SOD). To elucidate the effects
on apoptosis, AKT was detected by ELISA. FAS, anti-apoptotic gene Bcl-2 and pro-
apoptotic gene Bax were examined by quantitive real time PCR. Furthermore,
secretion of vascular endothelial growth factor (VEGF) was determined by ELISA.
Nitric oxide (NO) release was also been investigated.
Results: Clearly demonstrated time-dependent progression of heart dysfunction by
gradually decreased ejection fraction (EF), LV fractional shortening (FS), LV end-
systolic dimension (LVSD), LV end-diastolic volume (LVEDD), and the blood ﬂow
of LV outﬂow tract (LVOT) in ADM group. Meanwhile, the decreased cardiac
function could be obviously improved by DHI especially in peak vel of LVOT. Aortic
ring assay showed strongly reducing endothelium-dependent vasodilator responses by
ADM and a signiﬁcant increase in vasodilatation induced by Ach with DHI. DHI (10-4,
10-3, 10-2, 10-1 g/L) could improve cell viability against ADM injury (10-6 M) ac-
cording to MTT and LDH results. Furthermore, the release of SOD was signiﬁcantly
increased by DHI compare with ADM. RT-PCR showed decreased mRNA expression
of Bcl-2/Bax as well as enhanced expression of FAS in ADM group. Treatment with
DHI could upregulate Bcl-2/Bax and inhibit FAS. Besides, DHI could reverse ADM
decreased AKT levels. Notably, DHI also prevented VEGF expression but couldn’t
affect the suppressed NO generation by ADM.
Conclusions: This study indicated that DHI has protective effects against ADM-
induced cardiac dysfunction which might related to antagonize oxidative stress with
subsequent anti-apoptosis and improve endothelial function. The results may provide
a rational basis for Danhong injection to be an antidote to cardiac toxicity induced by
ADM in clinic.
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Objectives: Treatment based on syndrome differentiation has been one of the most
distinctive characteristics in the theory of traditional Chinese medicine (TCM). Based
on this theory, different diseases could be treated using the same method provided
they presented with the same syndrome. Xuefu Zhuyu Capsule as a prototype of
Chinese patent medicine has been used for many years in the treatment of blood stasis
syndrome. We tried to take this medicine as an example to introduce the connotation
of this theory according to evidence based medicine (EBM) methodology.
Objective: Take the clinical application of Xuefu Zhuyu Capsule for blood stasis
syndrome as an example to explain the TCM theory - treating different diseases with
the same method.
Methods: An extensive systemic literature review was done in January 2014. We
searched the following databases: PubMed, CENTRAL and Chinese full text data base
with the key words Xuefu Zhuyu Capsule (published before Jan 1st 2014). As Ran-
domized Controlled Clinical Trials (RCTs) were the golden standard to estimate an
intervention we just included the RCTs in this study. A Microsoft Access database
was established to collect the related data as subject information, intervention and
outcomes. We also evaluated and analyzed the methodological quality of each RCT to
validate their ﬁndings.
Results: 125 RCTs were included in this study. The ﬁrst one published in 1998. And
the methodological quality control of most trials was limited. Among the included
studies there was obvious clinical heterogeneity such as protopathy, duration, doses
and control intervention within the same disease. The inclusion criteria were not
uniform either. In these studies doses of Xuefu Zhuyu Capsule was used from 6 pills
to 18 pills per day. The shortest duration was 4 days and the longest reached to 1 year.
Most of the study did not mention the adverse reaction. Thus, meta-analysis was not
suitable for such studies that had so much heterogeneity. We just did some descriptive
analysis. In this study, more than 20 kinds of diseases with the syndrome of blood
stasis in the ﬁelds of internal medicine, gynaecology, orthopedics, dermatology and
otorhinolaryngology were treated by Xuefu Zhuyu Capsule. Studies of coronary heart
disease occupied the ﬁrst place. The treatment was effective in most of the diseases
with statistically signiﬁcant difference between test and control groups. But the pool
quality control of the included studies seriously affected the promotion and application
of the research results.j October 16–19, 2014 j GW-ICC Abstracts/Cardiac Rehabilitation
